Effect of co_administration of vitamins A and D in patients with pneumosepsis

Effect of co_administration of vitamins A and D on symptoms in patients with pneumosepsis: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130424013110N11

Enrollment

Registered

2020-10-05

Start date

2020-10-22

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumosepsis. Other sepsis

Interventions

Intervention 1: Intervention group: First (intervention) group receive, 300000 unit vitamin D (1 milliliter), Intramuscular (IM) with 50000 unit vitamin A (1 milliliter), Intramuscular (IM) as a singl

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 18 to 80 years old Patients satisfaction Confirmed pneumosepsis disease

Exclusion criteria

Exclusion criteria: Unwillingness to cooperate Using Vitamin D supplements before intervention in the last three months Pregnancy

Design outcomes

Primary

Measure	Time frame
CRP. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Cr. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Serum uric acid level. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Serum urea level. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Measuring systolic and diastolic blood pressure. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Digital pressure indicator gauge.;Pulse rate. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Radial Pulse.;Respiratory rate. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Observation chest in a minute.;Temperatures. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Thermometer.;Measuring arterial oxygen percentage. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Pulse oximetry device.;WBC. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Cell blood count test.;ESR. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.	—

Measure

Time frame

CRP. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Cr. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Serum uric acid level. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Serum urea level. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.;Measuring systolic and diastolic blood pressure. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Digital pressure indicator gauge.;Pulse rate. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Radial Pulse.;Respiratory rate. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Observation chest in a minute.;Temperatures. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Thermometer.;Measuring arterial oxygen percentage. Timepoint: Before and every 6 hours after the intervention. Method of measurement: Pulse oximetry device.;WBC. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Cell blood count test.;ESR. Timepoint: Before and 24, 48 and 72 hours after the intervention. Method of measurement: Based on Lab data.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactelham niyasti

Arak University of Medical Sciences

dr.a.jokar@gmail.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026